Aging and Western Diet Team Up to Sabotage Liver Thyroid Hormone Signaling
A mouse study reveals how aging and poor diet synergistically disrupt liver thyroid hormone metabolism, accelerating fatty liver disease — and why resmetirom may help.
Summary
Researchers found that aging and a Western-style diet don't just independently harm the liver — they work together to cripple the liver's ability to use thyroid hormone effectively. In mice, this combination dramatically reduced levels of active thyroid hormone (T3) in liver tissue by disrupting the enzymes that convert and regulate it. The result was accelerated liver inflammation and scarring consistent with advanced fatty liver disease (MASLD/MASH). Interestingly, the FDA-approved drug resmetirom, which mimics thyroid hormone in the liver, reversed many of these aging-related changes in liver cells, including reducing cellular senescence and inflammation. These findings open a new window into why older adults on poor diets are especially vulnerable to serious liver disease.
Detailed Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as non-alcoholic fatty liver disease — affects hundreds of millions globally and worsens dramatically with age. Despite this, the biological mechanisms linking aging to accelerated liver deterioration have remained poorly understood. This study zeroes in on a previously underappreciated culprit: impaired thyroid hormone signaling within the liver itself.
Researchers compared young (18–24 weeks) and old (108–120 weeks) mice fed either a normal diet or a Western diet high in fat and fructose for 8 weeks. They measured liver histology, metabolic markers, inflammation, fibrosis, and crucially, the activity of enzymes (deiodinases) that activate or inactivate thyroid hormone inside liver cells.
The results were striking. Aging alone reduced the activity of Dio1, the enzyme that converts inactive T4 into active T3, lowering intrahepatic thyroid hormone availability. Western diet further compounded this by independently altering Dio3, the enzyme that breaks down T3. Together, aging and diet synergistically depleted active T3 in the liver, amplifying inflammation and fibrosis beyond what either factor caused alone. These findings were replicated in a senescent hepatocyte cell model.
Perhaps the most clinically exciting finding is the behavior of resmetirom — an FDA-approved thyromimetic drug — in this context. In senescent liver cells, resmetirom reduced hallmarks of cellular aging including the inflammatory secretory phenotype (SASP), inflammasome activation, and ER stress, while also activating autophagy. This suggests the drug may have therapeutic utility beyond its approved indication.
For clinicians and longevity-focused individuals, this study highlights that liver thyroid hormone status — not just systemic thyroid levels — may be a critical but overlooked driver of age-related liver disease. The synergy between aging and dietary stress underscores the urgency of dietary intervention in older adults at risk for MASLD.
Key Findings
- Aging and Western diet synergistically reduce active T3 (thyroid hormone) levels inside the liver, worsening fatty liver disease.
- Aging decreases Dio1 enzyme activity, impairing conversion of T4 to active T3 in liver tissue.
- Dio3 (the T3-inactivating enzyme) increases with age, further depleting liver thyroid hormone availability.
- Resmetirom reduced cellular senescence markers, inflammation (SASP), ER stress, and activated autophagy in aging liver cells.
- Systemic thyroid levels may be normal while intrahepatic thyroid signaling is critically impaired — a key diagnostic blind spot.
Methodology
Young (18–24 weeks) and old (108–120 weeks) C57BL/6J mice were fed normal chow or a Western diet with fructose for 8 weeks in a 2x2 factorial design. Liver histology, deiodinase enzyme activities, intrahepatic T4/T3 concentrations, and inflammatory/fibrotic markers were assessed. An in vitro hepatocyte senescence model (AML12 cells) was used to evaluate resmetirom's therapeutic effects on aging-related changes.
Study Limitations
This study was conducted entirely in mice, limiting direct translation to human physiology and liver disease progression. The Western diet model, while informative, may not fully replicate the complexity of human dietary patterns and MASLD development. Critically, this summary is based on the abstract only, as the full text was not available; details on statistical power, effect sizes, and mechanistic depth could not be fully assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: